Ian Goodenough (Moore, Liberal Party) Share this | Hansard source

There are 130,000 Australians with type 1 diabetes. It is a condition that is growing at the rate of 3,500 patients per year and affects many people in my electorate of Moore. I welcome the announcement by the health minister this week that the federal government will invest an extra $100 million over four years to support patients with type 1 diabetes by making continuous glucose monitoring devices available to more than 37,000 Australians. This new initiative will save families up to $7,000 per year. From 1 March 2019, eligibility for fully subsidised continuous glucose monitoring devices will be expanded under the National Diabetes Services Scheme to include: women with type 1 diabetes while pregnant, breastfeeding or actively planning a pregnancy; people with type 1 diabetes who are 21 years or older who have concessional status and who have high clinical need, such as those experiencing recurrent severe hypoglycemic events; children and young people with conditions similar to type 1 diabetes who require insulin—this includes a range of conditions, such as cystic fibrosis related diabetes or neonatal diabetes. Expanding access to these glucose monitoring devices may offer many other health benefits, including reducing stress and anxiety.

See this speech in context